Immunotherapy: Trials and Tribulations

Enjoy complimentary access to this article collection for a limited time!

• A Serum Protein Signature Associated with Outcome after Anti–PD-1 Therapy in Metastatic Melanoma
  Weber JS…Roder H Cancer Immunology Research January 2018.
• Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
  Li C…Zhu Y Cancer Immunology Research February 2018.
• Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort
  Iorgulescu JB…Smith TR Cancer Immunology Research September 2018.
• High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model
  Richman SA…Milone MC Cancer Immunology Research January 2018.
• Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
  Baumeister SH...Nikiforow S Cancer Immunology Research January 2019.
• Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer Metastases
  Magee MS…Snook AE Cancer Immunology Research May 2018.
• Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC
  Santini FC…Hellmann MD Cancer Immunology Research September 2018.